Search
Now showing items 1-4 of 4
Trends in oral anticoagulant use in Qatar: a 5-year experience
(
Springer New York LLC
, 2017 , Article)
In Qatar, dabigatran was introduced in 2011 followed by rivaroxaban in 2014. In this study, we aim to explore the trends in oral anticoagulant use in Qatar over the past 5 years and to what extent did DOACs replace warfarin. ...
Trends of use of SGLT2 inhibitors in Qatar
(
Qatar University Press
, 2021 , Poster)
Background: Type 2 diabetes mellitus (T2DM) represents a growing health challenge in Qatar and worldwide. T2DM is associated with a high risk of cardiovascular (CV) morbidity and mortality, and progression of renal disease. ...
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country
(
Springer Science and Business Media Deutschland GmbH
, 2022 , Article)
Background: Sodium glucose co-transporter 2 inhibitors (SGLT2is) are a novel class of oral antidiabetic drugs. To date, there are no pharmacoepidemiologic studies investigating the pattern of use of SGLT2is compared to ...
Cost-effectiveness research in cancer therapy: A systematic review of literature trends, methods and the influence of funding
(
BMJ Publishing Group
, 2017 , Article Review)
Objective To perform a first-time analysis of the cost-effectiveness (CE) literature on chemotherapies, of all types, in cancer, in terms of trends and change over time, including the influence of industry funding.
Design ...